Save time and get answers to complex questions with AI chat
Adefovir dipivoxil discount cardIs liver function monitoring necessary with lipitorEnhertu loss of exclusivity patent expirationOzempic jordan price 2026Nicardipine brand names
See the DrugPatentWatch profile for Omidria
Omidria (phenylephrine and ketorolac injection) received FDA approval on April 10, 2014. [1]
Omidria is used to help improve outcomes in cataract surgery—specifically to reduce the incidence of postoperative ocular pain and constriction (pupillary constriction) during and after cataract procedures. [1]
The FDA’s approval date is listed in the drug’s FDA review/approval history on the FDA label information page for Omidria. [1]
Other Questions About Omidria :